US 11299549
Humanized BCMA antibody and BCMA-CAR-T cells
granted A61KA61K2035/124A61K2039/505
Quick answer
US patent 11299549 (Humanized BCMA antibody and BCMA-CAR-T cells) held by Caribou Biosciences, Inc. expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Caribou Biosciences, Inc.
- Grant date
- Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2035/124, A61K2039/505, A61K2039/54, A61K2039/804